Straits Times Index
3,415.51 +47.61 (+1.41%) S&P 500
5,537.02 +28.01 (+0.51%) Dow
39,308.00 -23.85 (-0.06%) Nasdaq
18,188.30 +159.54 (+0.88%) Bitcoin USD
59,623.67 -2,192.64 (-3.55%) CMC Crypto 200
1,255.27 -79.65 (-5.97%)
Exor N.V. (EXO.AS)
| Previous close | 97.05 |
| Open | 96.80 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 96.65 - 98.95 |
| 52-week range | 78.60 - 106.30 |
| Volume | |
| Avg. volume | 163,183 |
| Market cap | 33.345B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 5.34 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.46 (0.47%) |
| Ex-dividend date | 30 May 2024 |
| 1y target est | N/A |
- Reuters
Agnellis' Exor targets growth in healthcare sector
Exor, the investment arm of the Agnelli family, has a growing interest in the healthcare industry, where it has already invested almost 4 billion euros ($4.3 billion), CEO John Elkann said on Thursday. "The increased cost of healthcare services combined with a shortage of medical staff is driving demand for innovative new approaches to tackle global health problems," he said in his annual letter to Exor shareholders. Exor views healthcare as a "long-term, structural growth sector," added Elkann, the scion of the Agnelli family and chair of automakers Stellantis and Ferrari.
- Reuters
UPDATE 1-Agnellis' Exor targets growth in healthcare sector
Exor, the investment arm of the Agnelli family, has a growing interest in the healthcare industry, where it has already invested almost 4 billion euros ($4.3 billion), CEO John Elkann said on Thursday. "The increased cost of healthcare services combined with a shortage of medical staff is driving demand for innovative new approaches to tackle global health problems," he said in his annual letter to Exor shareholders. Exor views healthcare as a "long-term, structural growth sector," added Elkann, the scion of the Agnelli family and chair of automakers Stellantis and Ferrari.
- Reuters
Exor has growing interest in healthcare industry
Exor, the investment arm of the Agnelli family, has a growing interest in the healthcare industry, where it has already invested almost 4 billion euros ($4.3 billion), CEO John Elkann said on Thursday. "The increased cost of healthcare services combined with a shortage of medical staff is driving demand for innovative new approaches to tackle global health problems," he said in his annual letter to Exor shareholders. Exor views healthcare as a "long-term, structural growth sector," said Elkann, the scion of the Agnelli family and chair of automakers Stellantis and Ferrari.
